{
    "2019-09-27": [
        [
            {
                "time": "",
                "original_text": "早盘反弹未果，仿制药板块再跌， “4+7”扩采搅动行业格局渐现",
                "features": {
                    "keywords": [
                        "早盘反弹",
                        "仿制药",
                        "4+7",
                        "扩采",
                        "行业格局"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "卫健委主任：一定不要再出现“中标死”",
                "features": {
                    "keywords": [
                        "卫健委",
                        "中标死"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-09-27",
                "original_text": "9月27日券商晨会研报汇编",
                "features": {
                    "keywords": [
                        "券商",
                        "晨会",
                        "研报"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药品带量采购扩围谁是大赢家：以价换量能为药企增厚多少利润",
                "features": {
                    "keywords": [
                        "药品",
                        "带量采购",
                        "扩围",
                        "以价换量",
                        "药企",
                        "利润"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}